TD Cowen maintains Buy rating on Visteon, $131 price target

TD Cowen maintained a Buy rating on Visteon with a $131 price target, suggesting a 60.3% upside from the Oct 22 close. The firm cited strong revenue growth prospects and undervaluation at 4x EV/EBITDA, supported by a robust pipeline and net cash balance.

Original reporting
Published Oct 23, 2026, 1:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 23, 2026, 1:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
TD Cowen maintains Buy rating on Visteon, $131 price target — source image
Decision brief

The 30-second read

Med
01

Why it matters

The upgrade could trigger short‑term buying and raise the stock toward the $131 target.

02

Market read

Analyst rating change with a higher price target provides a fresh catalyst for Visteon.

03

What to watch

Potential supply-chain constraints and macro headwinds could limit upside.

Relevance 7/10Novelty 6/10Timing: today

Background

TD Cowen's note follows Visteon's recent earnings and outlines a multi‑year growth outlook.

Market effects

Positive outlook for automotive electronics may lift peers in the sector.

Limited to US auto parts market.

Minor, confined to Visteon and related suppliers.

Counterpoint

The target may be overly optimistic if revenue growth stalls.

Key entities

  • TD Cowen

    Equity research firm issuing the rating.

  • Visteon

    Automotive electronics supplier.

Related articles

Med

Visteon Corporation Q3 2026 Earnings Call Summary

Visteon Corporation reported Q3 2026 earnings, highlighting 10 percentage points of market outperformance despite a 5% decline in vehicle production. The company addressed $77 million in warranty charges and managed inflation in PCBs. For 2027, Visteon anticipates $500 million in incremental costs and aims to maintain EBITDA targets through customer recoveries. China sales are expected to grow in Q4 2026, driven by high-performance compute launches.

Med

Visteon (VC) Q3 2026 Earnings Call Transcript

Visteon (VC) reported Q3 2026 earnings, highlighting a $200M share repurchase and sales growth despite market challenges. Sales grew in Americas, Europe, and Asia (excluding China), with China sales expected to recover in Q4. The company launched 21 new products, including high-value cockpit technologies, and secured $1B in new business bookings, targeting $6B for the year. Strategic wins include programs with Toyota, Maruti Suzuki, and Tata Motors.

$VCMedAI 8/10

What Visteon (VC) Said on Its Q3 Earnings Call

Visteon (VC) reported Q3 earnings, noting regional sales trends and product launches. Sales rose 14% in Asia excluding China, but faced challenges in the Americas and China. The company expects China sales to grow in Q4 with new launches. Visteon launched 21 products and booked $1B in new business, maintaining its $6B annual target. It updated guidance, raising full-year sales to $3.8B-$3.85B but lowering adjusted EBITDA to $370M-$410M. Q4 sales are expected to be $940M, flat YoY.

$VCHighAI 8/10

Visteon Q3 2026 slides: strong growth offset by warranty charges

Visteon (VC) reported Q3 2026 sales of $970M, up 6% YoY, but adjusted EBITDA fell to $46M due to $77M in warranty charges. Europe and Rest of Asia drove growth, while Americas and China faced declines. The company launched 21 new products, including a High Performance Compute system for Chery. VC stock dropped 5.58% post-earnings.